HR 8205·Federal·house
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Floor Vote ScheduledFiled Apr 6, 2026
Sponsor: Rep. Quigley, Mike [D-IL-5] (D)
Latest Action
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 466.
Jul 23, 2026
Summary
The bill renews a program aimed at getting important treatments to people with amyotrophic lateral sclerosis (ALS) more quickly. It affects ALS patients, their doctors, and researchers by trying to reduce delays in therapy availability. The measure is intended to improve health outcomes for those living with this progressive disease.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 8205 changes status, plus AI-powered summaries and stage predictions.
Sign up free